← Back to Search

AC+ARwdC for Treatment Compliance

N/A
Waitlist Available
Led By Chad Stecher, PhD
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from post-intervention (week 8) to follow-up (week 16)
Awards & highlights

Study Summary

This trial will test the feasibility of a novel intervention to establish persistent meditation adherence with a mobile app. The investigators hypothesize that the use of anchoring strategies in combination with pragmatic in-kind rewards will be more effective than usual care in establishing persistent meditation adherence.

Eligible Conditions
  • Treatment Compliance
  • Stress

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from post-intervention (week 8) to follow-up (week 16)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from post-intervention (week 8) to follow-up (week 16) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean Adherence Persistence Over Weeks 1-8
Mean Adherence Persistence Over Weeks 8-16
Secondary outcome measures
Anxiety
Habit Strength
Mindfulness
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: AC+RwdCExperimental Treatment1 Intervention
Prescribed Calm usage = 10 minutes a day; Personalized anchoring plan for initiating any available meditation; Weekly text message reminders during the intervention period to reinforce the use of their anchoring plan; In-kind rewards if they meditate on at least 8 days out of every 2 weeks (i.e., 14 days) during the 8 week intervention period (i.e., eligible for 4 prizes); $20 incentive for completing the baseline, week 8, and week 16 surveys
Group II: AC+ARwdCExperimental Treatment1 Intervention
Prescribed Calm usage = 10 minutes a day; Personalized anchoring plan for initiating any available meditation; Weekly text message reminders during the intervention period to reinforce the use of their anchoring plan; In-kind rewards only if they meditate using their anchoring plan on at least 8 days out of every 2 weeks (i.e., 14 days) during the 8 week intervention period (i.e., eligible for 4 prizes); $20 incentive for completing the baseline, week 8, and week 16 surveys
Group III: Usual Calm Control (UC)Active Control1 Intervention
Prescribed Calm usage = 10 minutes a day; Personalized anchoring plan for initiating any available meditation; $20 incentive for completing the baseline, week 8, and week 16 surveys
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AC+ARwdC
2022
N/A
~600
AC+RwdC
2022
N/A
~600

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
283 Previous Clinical Trials
108,917 Total Patients Enrolled
Calm.com, Inc.Industry Sponsor
6 Previous Clinical Trials
771 Total Patients Enrolled
Chad Stecher, PhDPrincipal InvestigatorArizona State University
2 Previous Clinical Trials
399 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Incentivizing Meditation App Habit Formation
2022. "Incentivizing Meditation App Habit Formation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05217602.
~194 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top